XRHealth, the gateway to the healthcare metaverse, announced the integration of Tobii’s medical-grade eye-tracking technology to their virtual reality (VR) platform, which is used for therapy sessions. This new addition will allow clinicians to train and treat patients with neurological conditions like Parkinson’s Disease, Multiple Sclerosis, and Autism.
Tobii eye tracking is integrated into the Pico Neo 3 Pro Eye headsets, powered by the Qualcomm Snapdragon™ XR2 Platform. The integration helps clinicians better measure and diagnose neurological conditions and treat symptoms, including increasing attention span and improving eye contact. An example of how eye tracking can be incorporated into therapeutic sessions would be using it to measure the patient’s pupil as a biomarker for stress and anxiety. With the new eye-tracking capabilities, clinicians can also track treatment progress to clearly quantify the healthcare outcome.
“We are equipping our patients with the latest virtual reality technology so that they have access to the best healthcare experience available today,” says Eran Orr, Founder & Chief Executive Officer at XRHealth. “We are excited to partner with Tobii – the leader in eye tracking – which will significantly improve patient treatment with accurate neurological measurements to provide markers for success.”
XRHealth’s virtual reality platform provides data and insights to patients and clinicians in real-time so that all treatments can be measured during therapy and adjusted as needed.
“At Tobii, our mission is to create a better future for everyone through innovative technology,” said Johan Hellqvist, VP of XR at Tobii. “XRHealth’s eye-tracking integration to their VR platform proves once again that our technology positively impacts people’s health and lives. As a company, we are committed to catalyzing the commercialization of healthcare innovations and working with partners to address challenges.”